Secarna Pharmaceuticals patents novel anti-CD39 immunosuppression-reverting oligonucleotides May 8, 2018 No Comments
Afecta Pharmaceuticals patents novel hgh mobility group protein B1 inhibitors April 25, 2018 No Comments